Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010

References

• BurneyPSuissaSSorianoJBThe pharmacoepidemiology of COPD: recent advances and methodological discussionEur Respir J Suppl2003431s44s14582902
   PubMedGoogle Scholar
• MurrayCJLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet19973499064149815049167458
   PubMed Web of Science ®Google Scholar
• Lopez VarelaMVMontes de OcaMHalbertRComorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO studyArch Bronconeumol2013491146847423856439
   PubMed Web of Science ®Google Scholar
• GershonASGuanJVictorJCGoldsteinRToTQuantifying health services use for chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187659660123328526
   PubMed Web of Science ®Google Scholar
• ChiangCHCost analysis of chronic obstructive pulmonary disease in a tertiary care setting in TaiwanRespirology200813568969418513247
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• van RanstDStoopWAMeijerJWOttenHJvan de PortIGReduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation programInt J Chron Obstruct Pulmon Dis201491059106725336938
   PubMed Web of Science ®Google Scholar
• KruisALSmidtNAssendelftWJCochrane corner: is integrated disease management for patients with COPD effective?Thorax201469111053105524415716
   PubMed Web of Science ®Google Scholar
• ChengSLChanMCWangCCCOPD in Taiwan: a National Epidemiology SurveyInt J Chron Obstruct Pulmon Dis2015102459246726648708
   PubMed Web of Science ®Google Scholar
• LimSLamDCMuttalifARImpact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based surveyAsia Pac Fam Med2015141425937817
   PubMedGoogle Scholar
• LindenauerPKStefanMSShiehMSPekowPSRothbergMBHillNSOutcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary diseaseJAMA Intern Med2014174121982199325347545
   PubMed Web of Science ®Google Scholar
• YangHHLaiCCWangYHSevere exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonistInt J Chron Obstruct Pulmon Dis2017122477248528860742
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
   PubMed Web of Science ®Google Scholar
• WilsonDHTuckerGFrithPAppletonSRuffinREAdamsRJTrends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993–2003Med J Aust2007186840841117437395
   PubMed Web of Science ®Google Scholar
• FuhrmanCRocheNVergnenegreAZureikMChouaidCDelmasMCHospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998–2007Respir Med2011105459560121130636
   PubMed Web of Science ®Google Scholar
• de Miguel-DiezJJimenez-GarciaRHernandez-BarreraVTrends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010Respir Med2013107571772323421969
   PubMed Web of Science ®Google Scholar
• FordESCroftJBManninoDMWheatonAGZhangXGilesWHCOPD surveillance – United States, 1999–2011Chest2013144128430523619732
   PubMed Web of Science ®Google Scholar
• MorettiAMTafuriSParisiDGerminarioCEpidemiology and costs of hospital care for COPD in PugliaMultidiscip Respir Med20116529930422958809
   PubMed Web of Science ®Google Scholar
• EsquinasAMZamarro GarciaCRey TerronLTrends of hospital admissions for acute exacerbation of COPD in Spain: are we needing a new of hospital and health system organization reappraisal?Respir Med201410871066106724820244
   PubMed Web of Science ®Google Scholar
• BaillargeonJWangYKuoYFHolmesHMSharmaGTemporal trends in hospitalization rates for older adults with chronic obstructive pulmonary diseaseAm J Med2013126760761423688662
   PubMed Web of Science ®Google Scholar
• FriedmanMMenjogeSSAntonSFKestenSHealthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD)Pharmacoeconomics2004221174174915250751
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
   PubMed Web of Science ®Google Scholar
• NielsenRKankaanrantaHBjermerLCost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countriesRespir Med2013107111709172123856511
   PubMed Web of Science ®Google Scholar
• DalalAAShahMD’SouzaAOMapelDWCOPD-related healthcare utilization and costs after discharge from a hospitalization or emergency department visit on a regimen of fluticasone propionate-salmeterol combination versus other maintenance therapiesAm J Manag Care2011173e55e6521504260
   PubMed Web of Science ®Google Scholar
• FletcherMJUptonJTaylor-FishwickJCOPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age populationBMC Public Health20111161221806798
   PubMed Web of Science ®Google Scholar
• van BovenJFVegterSvan der MolenTPostmaMJCOPD in the working age population: the economic impact on both patients and governmentCOPD201310662963923845002
   PubMedGoogle Scholar
• EstebanCQuintanaJMAburtoMPredictors of mortality in patients with stable COPDJ Gen Intern Med200823111829183418795373
   PubMed Web of Science ®Google Scholar
• LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
   PubMed Web of Science ®Google Scholar
• FumagalliGFabianiFForteSINDACO project: COPD and link between comorbidities, lung function and inhalation therapyMultidiscip Respir Med2015101425973198
   PubMedGoogle Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• ManninoDMHiguchiKYuTCEconomic burden of COPD in the presence of comorbiditiesChest2015148113815025675282
   PubMed Web of Science ®Google Scholar
• HoTWTsaiYJRuanSYHINT Study GroupIn-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based studyPLoS One2014912e11486625490399
   PubMed Web of Science ®Google Scholar
• AlmagroPCabreraFJDiezJComorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) studyChest201214251126113323303399
   PubMed Web of Science ®Google Scholar
• WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJSerra PonsIManninoDMMaasAKMillerDPDavisKJLung function impairment, COPD hospitalisations and subsequent mortalityThorax201166758559021515553
   PubMed Web of Science ®Google Scholar
• SuissaSDell’AnielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
   PubMed Web of Science ®Google Scholar